✦ LIBER ✦

1398 POSTER Efficacy of a novel hypoxic cell radiosensitizer PR-350 in the treatment of locally-advanced pancreatic cancer — A placebo-controlled randomized study

Book ID: 123452487
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 130 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(05)81689-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of novel hypoxic cell sensitise

Efficacy of novel hypoxic cell sensitiser doranidazole in the treatment of locally advanced pancreatic cancer: Long-term results of a placebo-controlled randomised study

✍ Katsuyuki Karasawa; Makoto Sunamura; Atsutake Okamoto; Kenji Nemoto; Seiki Matsu 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 76 KB

A phase 3 tRial comparing capecitabinE i

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial

✍ José Baselga, Frederico Costa, Henry Gomez, Clifford A Hudis, Bernardo Rapoport… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 246 KB

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors : A randomized, Phase III, double-blind, placebo-controlled trial

✍ Lee S. Rosen; David Gordon; N. Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

Preliminary results of a randomized stud

Preliminary results of a randomized study comparing the efficacy of 2 doses of docetaxel 100 mg/m2/3 weeks vs 75 mg/m2/3 weeks in treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of a previous cis-platin based chemotherapy

✍ Quoix, E; Lebeau, B; Jacoulet, P; Ducolonné, A; Moro, D; Milleron, B; Lemarié, E 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB